|
KMID : 1031120210110020136
|
|
Journal of Epilepsy Research
2021 Volume.11 No. 2 p.136 ~ p.141
|
|
|
Pulse Methylprednisolone with Oral Prednisolone versus Adrenocorticotropic Hormone in Children with West Syndrome: a Randomized Controlled Trial
|
|
Fatema Kanij
Rahman Mizanur
Hossain Mohammad Monir
Akhter Shaheen
Shomee Dewan Afsana
Akhter Sohela
Mannan Mazharul
|
|
|
Abstract
|
|
|
Background and Purpose: West syndrome is an epileptic encephalopathy of infancy. According to guidelines, adrenocorticotrophic hormone (ACTH) is probably effective for the short-term management of infantile spasm, but there is little uniformity in treatment due to variable response. This study has been done to evaluate the efficacy of pulse methylprednisolone as compared to ACTH in children with West syndrome.
Methods: Children between 3 months to 24 months with the diagnosis of West syndrome were included and ACTH and pulse methyl prednisolone followed by oral prednisolone were given after randomization. Total duration of treatment was 6 weeks in both groups.
Results: Total 87 children were enrolled; 12 patients lost in follow up. Finally, 43 received ACTH and 32 received pulse methylprednisolone. In pulse methylprednisolone group, 28.13% showed 50?80% response, 28.13% showed 80?99% response and 21.87% patients showed 100% response. In ACTH group, 41.86% showed 50?80% response, 25.58% showed 80?99% response and only 3 (6.97%) patients showed 100% response. Methylprednisolone treatment regimen did not cause significant or persistent adverse effects.
Conclusions: Pulse methylprednisolone followed by oral prednisolone for 6 weeks is as effective as ACTH. Thus, methylprednisolone therapy can be an important alternative to ACTH.
|
|
|
KEYWORD
|
|
|
West syndrome, Methylprednisolone, Adrenocorticotropic hormones
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|